The intention of this publication is to give an overview on research related to conjugates of
polysaccharides and peptides. Dextran, chitosan, and alginate were selected, to cover four …

Several nanoscale carriers (nanoparticles, liposomes, water-soluble polymers, micelles and
dendrimers) have been developed for targeted delivery of cancer diagnostic and therapeutic …

Affibody®(affibody) ligands that are specific for the extracellular domain of human epidermal
growth factor receptor 2 (HER2/neu) have been selected by phage display technology from …

New and innovative methods of delivery of therapeutic agents using polysaccharides have
been recently developed, which target site of action, increase the intensity and/or prolong …

Owing to their tunable blood circulation time and suitable plasma stability, polymer‐based
nanomaterials hold a great potential for designing and utilising multifunctional nanocarriers …

Progress in genomics and proteomics provides clinical oncology with new anti-cancer
drugs, which target selectively aberrantly expressed membrane proteins and associated …

INTRODUCTION: The cellular binding and processing of an epidermal growth factor
receptor (EGFR) targeting affibody molecule,(ZEGFR: 955) 2, was studied. This new and …

Overexpression of epidermal growth factor receptor (EGFR) has been implicated in tumor
development and malignancy. Evaluating the degree of EGFR expression in tumors could …

Publisher Summary Polysaccharides are made either of one type of small unit, or with two
alternating units that are not only informational molecules such as protein and nucleic acids …

Purpose Targeted delivery of radionuclides for diagnostic and therapeutic applications has
until recently largely been limited to receptor ligands, antibodies and antibody-derived …